Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Kempharm Inc (KMPH)

3.85 0.05 (1.32%)

12-12 11:00

Open:

3.85

Pre. Close:

3.8

High:

3.85

Low:

3.801

Volume:

2,846

Market Cap:

56M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.95 - 4.09

4.09 - 4.19

Low:

3.52 - 3.61

3.61 - 3.68

Close:

3.66 - 3.87

3.87 - 4.01

Technical analysis  (as of: 2017-12-12 10:42:52 AM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 4.61     One year: 5.39

Support:

Support1: 3.67    Support2: 3.50

Resistance:

Resistance1: 3.95    Resistance2: 4.61

Pivot:

3.72

Moving Averages:

MA(5): 3.74     MA(20): 3.73

MA(100): 3.50     MA(250): 3.73

MACD:

MACD(12,26): 0.01     Signal(12,26,9):

%K %D:

%K(14,3): 77.98     %D(3): 62.73

RSI:

RSI(14): 56.11

52-Week:

High: 5.4  Low: 2.45  Change(%): 13.2

Average Vol(K):

3-Month: 2808  10-Days 3596

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
KMPH has closed below upper band by 12.8%. Bollinger Bands are 40.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to KMPH's normal range. The bands have been in this narrow range for 43 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 16 Apr 2015 10:23:21 GMT
KemPharm Inc.

Wed, 01 Nov 2017 20:26:15 GMT
KemPharm, Inc. to Report Third Quarter 2017 Results

Thu, 10 Aug 2017 20:03:45 GMT
KemPharm, Inc. Reports Second Quarter 2017 Results

Thu, 16 Nov 2017 12:22:30 GMT
KemPharm Completes Successful End-of-Phase 2 Meeting on KP415 with FDA

Tue, 28 Feb 2017 12:22:30 GMT
KemPharm, Inc. to Report Fourth Quarter and Year End 2016 Results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

14.66

Shares Float (M)

8.38

% Held by Insiders

37.44

% Held by Institutions

36.37

Shares Short (K)

272

Shares Short Prior Month (K)

280

Stock Financials

EPS

-2.920

EPS Est. Current Year

-2.720

EPS Est. Next Year

-2.300

EPS Est. Next Quarter

-0.700

Forward EPS

-2.273

Book Value (p.s.)

-3.280

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-29.3

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.437

Qtrly Earnings Growth

Operating Cash Flow (M)

-35.52

Levered Free Cash Flow (M)

-23.39

atoplab.com

Valuation

P/E

-1.32

P/E Growth Ratio

0.01

P/BV

-1.17

P/S

P/CF

-1.59

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.